Company Description
ACADIA Pharmaceuticals puts genes and drugs together to fight disease. The development-stage company uses its proprietary R-SAT technology to...
Key ACADIA Pharmaceuticals Financials
| Company Type | Public - NASDAQ (GM): ACAD Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $7.6 |
| 2005 Employees | 112 |
More ACADIA Pharmaceuticals Financials (11 pages)
Competition
Competitive Landscape for Biotechnology Sector
Demand for biotechnology products and services is driven primarily by the willingness of insurers to pay for new medical treatments. The profitability of individual companies depends on the...
Read more about ACADIA Pharmaceuticals's competition across multiple industries
Top ACADIA Pharmaceuticals Competitors
Sponsored Links
The Business DirectoryTrading Toolbox
ACADIA Pharmaceuticals Executives sponsored by genius.com
| Title | Name & Bio | Contact |
|---|---|---|
| Chairman | Leslie L. Iversen | Network | E-mail |
| CEO and Director | Uli Hacksell | Network | E-mail |
| SVP Business Development | Brian Lundstrom | Network | E-mail |
More ACADIA Pharmaceuticals Executives
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current ACADIA Pharmaceuticals News
- ACADIA Pharmaceuticals Inc (ACAD) Corporate Event Announcement Notice [Wall Street Horizon] (09 Jul 2008 20:38:00 EDT)
- ACADIA Pharmaceuticals Inc (ACAD) Corporate Event Announcement Notice [Wall Street Horizon] (08 Jul 2008 20:38:00 EDT)
- IRON CATALYZED CROSS-COUPLING REACTIONS OF IMIDOYL DERIVATIVES [European Patents] (08 Jul 2008 16:53:00 EDT)